PANCREATIC CANCER NORTH AMERICA INC (EIN 845185853) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

Michelle Capobianco

Phone

8442743640

Tax Period

2024-01-01 to 2024-12-31

PANCREATIC CANCER NORTH AMERICA INC, founded in 2020, is a small nonprofit in the Health Care sector that reported $129K in total revenue in fiscal year 2024. Revenue decreased 9% compared to the prior year. Expenses of $167K exceeded revenue, resulting in a 30% operating deficit.

Mission

Pancreatic Cancer North America aims to fundamentally change the experience of pancreatic cancer for patients and their families, and redefine it from a death sentence to a survivable cancer.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $128,661

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $128,661

Expense Breakdown

Grants Paid $79,375

Salaries & Benefits $0

Fundraising Expenses $25,533

Program Expenses $102,084

Other Expenses $87,895

TOTAL EXPENSES $167,270

Year-over-Year Comparison

	2024	2023	Change
Revenue	$128,661	$140,713	-0.1%
Expenses	$167,270	$150,582	+0.1%
Net Income	$-38,609	$-9,869	+2.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jonathan Paul	Board Chair	1	Director	$0	$0	$0
Michael Gilbert	Board Vice Chair and Treasurer	1	Director	$0	$0	$0
Lauren Israel	Board Director	1	Director	$0	$0	$0
Russell Browne	Board Director	1	Director	$0	$0	$0
Christopher Andrews	Board Director	1	Director	$0	$0	$0
Elfreda Lau	Board Director	1	Director	$0	$0	$0
Linda Shick	Board Director	1	Director	$0	$0	$0
Richard Weldon	Board Director	1	Director	$0	$0	$0
Michelle Capobianco	President & CEO & Secretary	25	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$128,661	$167,270	$69,323	$-38,609
2023	$140,713	$150,582	$96,001	$-9,869
2022	$223,232	$255,696	$116,634	$-32,464
2021	$254,134	$116,128	$138,334	$138,006

PANCREATIC CANCER NORTH AMERICA INC